← Back to guidelines
Dermatology37 papers

Dermatitis herpetiformis

Last edited: 4/14/2026

Overview

Dermatitis herpetiformis (DH) is a chronic, intensely itchy skin condition triggered by gluten consumption, characterized by subepidermal blisters and IgA deposits in the skin, often associated with celiac disease 3.

Diagnosis

  • Clinical Presentation: Characteristic intensely pruritic papulovesicular lesions, typically symmetrically distributed on extensor surfaces 3.
  • Biopsy: Histopathological examination showing subepidermal blistering with IgA deposits on direct immunofluorescence 3.
  • Serology: Anti-tissue transglutaminase antibodies (tTG-IgA) and anti-endomysial antibodies (EMA) are often elevated 3.
  • Enteropathy Evaluation: Duodenoscopy with biopsy to assess for celiac disease-related enteropathy 3.
  • Management

  • First-Line Treatment: Dapsone, typically starting at 50-100 mg daily, adjusted based on response and tolerance 3.
  • Dietary Management: Strict adherence to a gluten-free diet is essential for long-term control 3.
  • Adjunctive Therapies: Topical corticosteroids for symptomatic relief of acute flares 3.
  • Monitoring: Regular follow-up to assess adherence to gluten-free diet and medication efficacy 3.
  • Special Populations

  • Pregnancy: Gluten-free diet remains crucial; dapsone use should be carefully monitored due to potential risks 11.
  • Comorbidities: Patients with thyroid disorders may require additional monitoring for immunologic associations 11.
  • Key Recommendations

  • Initiate Dapsone Therapy: Start with 50-100 mg daily for symptomatic relief and control of DH (Evidence: Strong 3).
  • Strict Gluten-Free Diet: Essential for long-term management and prevention of disease flares (Evidence: Strong 3).
  • Regular Monitoring: Include serological markers and clinical assessments to ensure adherence and treatment efficacy (Evidence: Moderate 3).
  • References

    1 Forde E, Van den Berghe L, Buijs M, Cardone A, Daly J, Franco P et al.. Practical recommendations for the management of radiodermatitis: on behalf of the ESTRO RTT committee. Radiation oncology (London, England) 2025. link 2 Behroozian T, Bonomo P, Patel P, Kanee L, Finkelstein S, van den Hurk C et al.. Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations. The Lancet. Oncology 2023. link00067-0) 3 Görög A, Antiga E, Caproni M, Cianchini G, De D, Dmochowski M et al.. S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV). Journal of the European Academy of Dermatology and Venereology : JEADV 2021. link 4 Pandit SA, Glass LRD. Non-glaucoma periocular allergic, atopic, and irritant dermatitis at an academic institution: A retrospective review. Orbit (Amsterdam, Netherlands) 2019. link 5 Tchanque-Fossuo CN, Isseroff RR, Silverstein MA. Fluoroscopy induced chronic radiation dermatitis should be included in the differential diagnosis of notalgia paresthetica. Dermatology online journal 2016. link 6 Berard P, Michel X, Menetrier F, Laroche P. Medical management of a cutaneous contamination. Health physics 2010. link 7 Haddad V, Lupi O, Lonza JP, Tyring SK. Tropical dermatology: marine and aquatic dermatology. Journal of the American Academy of Dermatology 2009. link 8 Campbell J, Lane C. Developing a skin-care protocol in radiotherapy. Professional nurse (London, England) 1996. link 9 Michaëlsson G, Ljunghall K. Patients with dermatitis herpetiformis, acne, psoriasis and Darier's disease have low epidermal zinc concentrations. Acta dermato-venereologica 1990. link 10 Boulware RJ, Allison JR, Harding SA. Radiation dermatitis: a case report. Cutis 1981. link 11 Callen JP, Weston WF, Chanda JJ. Dermatitis herpetiformis and thyrotoxicosis. International journal of dermatology 1979. link 12 Larsen FS, Heydenreich G, Christiansen JV. Comedo formation following cobalt irradiation. Dermatologica 1979. link

    Original source

    1. [1]
      Practical recommendations for the management of radiodermatitis: on behalf of the ESTRO RTT committee.Forde E, Van den Berghe L, Buijs M, Cardone A, Daly J, Franco P et al. Radiation oncology (London, England) (2025)
    2. [2]
    3. [3]
      S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV).Görög A, Antiga E, Caproni M, Cianchini G, De D, Dmochowski M et al. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
    4. [4]
    5. [5]
      Fluoroscopy induced chronic radiation dermatitis should be included in the differential diagnosis of notalgia paresthetica.Tchanque-Fossuo CN, Isseroff RR, Silverstein MA Dermatology online journal (2016)
    6. [6]
      Medical management of a cutaneous contamination.Berard P, Michel X, Menetrier F, Laroche P Health physics (2010)
    7. [7]
      Tropical dermatology: marine and aquatic dermatology.Haddad V, Lupi O, Lonza JP, Tyring SK Journal of the American Academy of Dermatology (2009)
    8. [8]
      Developing a skin-care protocol in radiotherapy.Campbell J, Lane C Professional nurse (London, England) (1996)
    9. [9]
    10. [10]
      Radiation dermatitis: a case report.Boulware RJ, Allison JR, Harding SA Cutis (1981)
    11. [11]
      Dermatitis herpetiformis and thyrotoxicosis.Callen JP, Weston WF, Chanda JJ International journal of dermatology (1979)
    12. [12]
      Comedo formation following cobalt irradiation.Larsen FS, Heydenreich G, Christiansen JV Dermatologica (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG